(Q30414643)

21 June 2017

title

Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor (English)

1 reference

21 June 2017

1 reference

1 reference

9

Axel Imhof

0 references

Manfred Jung

object named as

Manfred Jung

7

0 references

Herbert Waldmann

object named as

Herbert Waldmann

12

0 references

Roland Schüle

13

object named as

Roland Schüle

1 reference

21 June 2017

Dominica Willmann

1

1 reference

21 June 2017

Soyoung Lim

2

1 reference

21 June 2017

Stefan Wetzel

3

1 reference

21 June 2017

Eric Metzger

4

1 reference

21 June 2017

Anett Jandausch

5

1 reference

21 June 2017

Wolfram Wilk

6

1 reference

21 June 2017

Ignasi Forne

8

1 reference

21 June 2017

Andreas Janzer

10

1 reference

21 June 2017

Jutta Kirfel

11

1 reference

21 June 2017

Reinhard Buettner

14

1 reference

21 June 2017

language of work or name

English

0 references

publication date

28 June 2012

1 reference

International Journal of Cancer

21 June 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 June 2017

volume

131

1 reference

21 June 2017

issue

11

1 reference

21 June 2017

page(s)

2704-2709

1 reference

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 June 2017

cites work

1 reference

Prostate cancer diagnosis and management

21 January 2018

1 reference

Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence

21 January 2018

1 reference

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

21 January 2018

1 reference

LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer

21 January 2018

1 reference

trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.

21 January 2018

1 reference

Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications

21 January 2018

1 reference

Structural basis of histone demethylation by LSD1 revealed by suicide inactivation

21 January 2018

1 reference

Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes

21 January 2018

1 reference

Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1

21 January 2018

1 reference

Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors

21 January 2018

1 reference

Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes

21 January 2018

1 reference

Compound library development guided by protein structure similarity clustering and natural product structure

21 January 2018

1 reference

Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A

21 January 2018

1 reference

Dali server: conservation mapping in 3D

21 January 2018

1 reference

Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4

21 January 2018

1 reference

A Scaffold-Tree-Merging Strategy for Prospective Bioactivity Annotation of γ-Pyrones

21 January 2018

1 reference

Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element.

21 January 2018

1 reference

Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27555

1 reference

21 June 2017

1 reference